Hello @Redbar, Welcome back.
While you were away ResApp iteration towards learning from past debauchery is very commendable:
In a nutshell building an economic moat (brick by brick in a staggered way). This is what in Venture Capital world is known as “Build Once, Sell Twice model”
- Built new revenue streams- Cough counter which differentiates from background noise ( Thank you US trials)
- Shortened integration timelines- App clips via text message ( Thank you long integration process of Coviu and Phenix)
- Built(read:building )new verticals- Software Development kit( SDK) - Thank you RB and Sanofi
- Delighting customers- Extending SDK for consumer Asthma app for Astra Zeneca. Thank you for all of the above.
What has not changed: communication! I think it’s still Work in Progress. My view, they need a better entrepreneur.
imo
- Forums
- ASX - By Stock
- RAP
- Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos, page-11
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable